TOPIC 343: NEUROPSYCHOLOGICAL ASSESSMENT SYSTEM FOR CANCER PATIENTS

对于许多癌症幸存者来说，认知能力下降是一个主要的生活质量问题。各种可用的治疗方法对个人的影响是不同的，不幸的是，研究几乎没有提供关于具体治疗如何影响神经认知功能的指导。为了帮助研究人员填补这一信息空白，并最终为医生和患者提供指导，需要一个专门为癌症患者和幸存者的重复评估而设计的神经心理评估系统。Creare将开发癌症患者神经心理评估系统(NASCP)：一个专门针对癌症患者和幸存者的移动、自我管理、可重复的神经心理评估系统，由移动应用程序、符合HIPAA标准的安全服务器以及面向研究人员和临床医生的Web门户组成。NASCP的组成部分将在人体研究中进行评估。

Cognitive decline is a major quality-of-life concern for many cancer survivors. Thevarious available treatments affect individuals differently, and research has unfortunately provided little guidance on how specific treatments impact neurocognitive function. To help researchers fill this information gap and ultimately provide guidance to doctors and patients, a neuropsychological assessment system that is designed specifically for repeated assessment of cancer patients and survivors is needed.Creare will develop the Neuropsychological Assessment System for Cancer Patients(NASCP): a mobile, self-administered, repeatable neuropsychological assessment system specific to cancer patients and survivors comprising of a mobile app, a secure HIPAA-compliant server, and a web portal for researchers and clinicians. The components of the NASCP will be assessed in a human study.